申请人:Jerini AG
公开号:EP2305668A1
公开(公告)日:2011-04-06
The present invention is related to a compound of the formula (I):
or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having 1 heteroatom, wherein said heteroatom is N, and
R5-R8; R17 are as defined in the claims, and their use as bradykinin B2 receptor modulators.
本发明涉及一种式 (I) 的化合物:
或其药理学上可接受的盐、溶液或水合物,其中 A 是具有 1 个杂原子的 6 元杂芳基,所述杂原子是 N,以及
R5-R8; R17 如权利要求中定义,以及它们作为缓激肽 B2 受体调节剂的用途。